Source link : https://newshealth.biz/health-news/myeloma-drugs-comeback-nixed-by-fda-panel/
(MedPage Today) — The comeback story of belantamab mafodotin (Blenrep) hit a roadblock Thursday as the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted that the drug does not have a favorable benefit-risk profile in combination with either… Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/116562 Author : Publish date : 2025-07-17 21:01:00 Copyright for syndicated content belongs to the […]
The post Myeloma Drug’s Comeback Nixed by FDA Panel first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-17 21:01:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8